Real-world experience in older patients with diffuse large B-cell lymphoma treated in Latin America: A study by the Latin American study group of lymphoproliferative disorders (GELL).

Myrna Candelaria, Luis Villela,Maria-Alejandra Torres-Viera, Camila Peña,Macarena Roa, Daniela Zambrano,Perla R R Colunga-Pedraza, Arianna Robles-Rodríguez,Fernando Pérez-Jacobo, Ana Carolina Oliver,Maria Victoria Irigoín, Rosio Baena, Henry Idrobo,Sally R Paredes, Rosa Oliday, Denisse Castro,Efeen Montaño-Figueroa, Guillherme F Perini, Julio D Fernández-Aguila,Luis E Malpica, Brady E Beltran, Jorge J Castillo

Journal of geriatric oncology（2023）

引用 0|浏览7

暂无评分

摘要

The life expectancy will be 85 years for women and 80 for men in 2030 [ [1] Christensen K. Doblhammer G. Rau R. Vaupel J. Ageing populations: the challenges ahead. Lancet. 2009; 374: 1196-1208https://doi.org/10.1016/S0140-6736(09)61460-4 Abstract Full Text Full Text PDF PubMed Scopus (2486) Google Scholar ]. Diffuse large B-cell lymphoma (DLBCL) is the most frequent lymphoma worldwide. Its incidence increases with age, from 45 cases to 112 per 100,000 in individuals aged 60–64 years, and 80–84 years, respectively [ [2] Thieblemont C. Coiffier B. Lymphoma in older patients. J Clin Oncol. 2007; 25: 1916-1923https://doi.org/10.1200/JCO.2006.10.5957 Crossref PubMed Scopus (122) Google Scholar ].

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要